Azathioprine in giant cell arteritis/polymyalgia rheumatica: a double-blind study.
The ability of azathioprine to reduce the maintenance prednisolone requirement of 31 patients with polymyalgia rheumatica (PMR) or giant cell arteritis (GCA), or both, was tested in a double-blind placebo controlled study over one year. Clinical and laboratory assessments were made at four-weekly in...
Guardat en:
| Publicat a: | Ann Rheum Dis |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
1986
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1001834/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3511861/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.45.2.136 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|